Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-11
1997-04-22
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514248, 514249, 514253, 514256, 514259, 514260, 514272, 514274, 544234, 544238, 544288, 544335, 544336, 544353, 544254, 544408, 546 98, 546101, 546110, A61K 3147, A61K 3150, A61K 31505, C07D23700, C07D22106
Patent
active
056229615
ABSTRACT:
A series of benzoquinolin-3-ones are pharmaceuticals effective in treating conditions consequent on both Type I and Type II 5.alpha.-reductase.
REFERENCES:
patent: 4760071 (1988-07-01), Rasmusson
patent: 5017568 (1991-05-01), Holt et al.
patent: 5175155 (1992-12-01), Juniewicz
patent: 5250539 (1993-10-01), Hirsch et al.
patent: 5300294 (1994-04-01), Johnson
patent: 5302621 (1994-04-01), Kojima et al.
patent: 5356935 (1994-10-01), Audia
Liang T. Cascieri MA, Cheung AH, Reynolds G.F., Rasmusson GH(1985) Endocrinology 117(2) 571 -9.
Klein, et al., J. steroid Biochem., 30 (1-6), 119-130 (1988).
Kadohama, et al., JNCI, 74 (2), 475-486 (1985).
Brooks, et al., The Prostate, 18, 215-227 (1991).
Andriole, et al., The Prostate, 10, 189-197 (1987).
Gormley, Glenn J., Urol. Clin. North America, 18 (1), 93-98 (1991).
Audia James E.
McQuaid Loretta A.
Neubauer Blake L.
Rocco Vincent P.
Barrett Brian P.
Boone David E.
Eli Lilly and Company
Huang Evelyn
Ivy C. Warren
LandOfFree
5.alpha.-reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5.alpha.-reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5.alpha.-reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-341865